Editorial
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Crit Care Med. Nov 4, 2016; 5(4): 201-203
Published online Nov 4, 2016. doi: 10.5492/wjccm.v5.i4.201
New avenues for reducing intensive care needs in patients with chronic spinal cord injury
Pierre A Guertin
Pierre A Guertin, Department of Psychiatry and Neurosciences, Laval University, Québec City, QC G1V 0A6, Canada
Pierre A Guertin, Laval University Medical Center (CHU de Québec - CHUL), Québec City, QC G1V 4G2, Canada
Author contributions: Guertin PA solely contributed to all aspects of this editorial paper.
Conflict-of-interest statement: The author is also president and chief executive officer of Nordic Life Science Pipeline.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Pierre A Guertin, PhD, Professor, Laval University Medical Center (CHU de Québec - CHUL), 2705 Laurier Boulevard, RC-9800 (Neuroscience), Québec City, QC G1V 4G2, Canada. pierre.guertin@crchul.ulaval.ca
Telephone: +1-418-5254444 Fax: +1-418-6542753
Received: March 24, 2016
Peer-review started: March 24, 2016
First decision: May 16, 2016
Revised: July 5, 2016
Accepted: August 11, 2016
Article in press: August 15, 2016
Published online: November 4, 2016
Processing time: 224 Days and 11 Hours
Core Tip

Core tip: This editorial is one of the first articles to describe clearly the existence of an urgent medical need for new pharmacological products aimed at providing non-invasive solutions for spinal cord injury patients suffering chronically of urinary tract infection or pneumonia. Drugs capable of activating temporarily on demand activity in specific central networks of neurons that control respiration or micturition are of particular interest.